Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1986 2
1987 1
1988 1
1989 2
1996 3
1997 3
1998 1
1999 3
2000 6
2001 3
2002 5
2003 3
2004 4
2005 7
2006 6
2007 4
2008 7
2009 10
2010 9
2011 7
2012 7
2013 14
2014 17
2015 28
2016 17
2017 28
2018 32
2019 27
2020 35
2021 51
2022 40
2023 29
2024 35
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Results by year

Filters applied: . Clear all
Page 1
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. Among authors: lecomte t. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, Lecomte T, Assenat E, Bauguion L, Ychou M, Bouché O, Monard L, Lambert A, Hammel P; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. Among authors: lecomte t. JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829. JAMA Oncol. 2022. PMID: 36048453 Free PMC article. Clinical Trial.
Mindfulness-based therapy: a comprehensive meta-analysis.
Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, Chapleau MA, Paquin K, Hofmann SG. Khoury B, et al. Among authors: lecomte t. Clin Psychol Rev. 2013 Aug;33(6):763-71. doi: 10.1016/j.cpr.2013.05.005. Epub 2013 Jun 7. Clin Psychol Rev. 2013. PMID: 23796855
Validation francophone de la CASIG-rev – un outil clinique visant à soutenir le rétablissement des personnes avec un trouble psychiatrique: French validation of the CASIG-rev – a clinical personal recovery assessment for people with psychiatric disorders.
Lecomte T, Heyden I, Raffard S, Khazaal Y, Livet A, Power P, Roy MA, Abdel-Baki A, Corbière M. Lecomte T, et al. Can J Psychiatry. 2024 Oct;69(10):759-767. doi: 10.1177/07067437241261481. Epub 2024 Jul 21. Can J Psychiatry. 2024. PMID: 39033429 Free article. French.
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.
De La Fouchardière C, Malka D, Cropet C, Chabaud S, Raimbourg J, Botsen D, Launay S, Evesque L, Vienot A, Perrier H, Jary M, Rinaldi Y, Coutzac C, Bachet JB, Neuzillet C, Williet N, Desgrippes R, Grainville T, Aparicio T, Peytier A, Lecomte T, Roth GS, Thirot-Bidault A, Lachaux N, Bouché O, Ghiringhelli F. De La Fouchardière C, et al. Among authors: lecomte t. J Clin Oncol. 2024 Mar 20;42(9):1055-1066. doi: 10.1200/JCO.23.00795. Epub 2024 Jan 17. J Clin Oncol. 2024. PMID: 38232341 Clinical Trial.
[Some Key Steps for App Design].
Khazaal Y, Potvin S, Pennou A, Djomo W, Borgeat F, Lecomte T. Khazaal Y, et al. Among authors: lecomte t. Sante Ment Que. 2021 Spring;46(1):119-134. Sante Ment Que. 2021. PMID: 34597491 Free article. Review. French.
Altered Biodistribution of 68Ga-DOTATOC.
Dupont AC, Borrelly F, Lecomte T, Maia S, Santiago Ribeiro MJ. Dupont AC, et al. Among authors: lecomte t. Clin Nucl Med. 2021 Feb 1;46(2):164-165. doi: 10.1097/RLU.0000000000003439. Clin Nucl Med. 2021. PMID: 33234939
Endoscopic and histologic characteristics of serrated lesions.
Moussata D, Boschetti G, Chauvenet M, Stroeymeyt K, Nancey S, Berger F, Lecomte T, Flourié B. Moussata D, et al. Among authors: lecomte t. World J Gastroenterol. 2015 Mar 14;21(10):2896-904. doi: 10.3748/wjg.v21.i10.2896. World J Gastroenterol. 2015. PMID: 25780286 Free PMC article. Review.
Remote cognitive assessment in severe mental illness: a scoping review.
Lavigne KM, Sauvé G, Raucher-Chéné D, Guimond S, Lecomte T, Bowie CR, Menon M, Lal S, Woodward TS, Bodnar MD, Lepage M. Lavigne KM, et al. Among authors: lecomte t. Schizophrenia (Heidelb). 2022 Mar 5;8(1):14. doi: 10.1038/s41537-022-00219-x. Schizophrenia (Heidelb). 2022. PMID: 35249112 Free PMC article. Review.
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma.
Fraunhoffer N, Hammel P, Conroy T, Nicolle R, Bachet JB, Harlé A, Rebours V, Turpin A, Ben Abdelghani M, Mitry E, Biagi J, Chanez B, Bigonnet M, Lopez A, Evesque L, Lecomte T, Assenat E, Bouché O, Renouf DJ, Lambert A, Monard L, Mauduit M, Cros J, Iovanna J, Dusetti N. Fraunhoffer N, et al. Among authors: lecomte t. Ann Oncol. 2024 Sep;35(9):780-791. doi: 10.1016/j.annonc.2024.06.010. Epub 2024 Jun 19. Ann Oncol. 2024. PMID: 38906254 Free article.
385 results